Resapp Health Limited

( ASX:RAP ) - Health Care Equipment & Services


Analyst Views

RAP – Morgans rates as Add

The company expects to report the headline results from two clinical studies by mid this year. The company has now enrolled 640 patients in its SMARTCOUGH-C-2 study to evaluate the efficacy of the ResAppDx smartphone application in the diagnosis of childhood respiratory diseases.

Read More